A.R.T. Advisors’s Molecular Templates, Inc. MTEM Stock Holding History

A.R.T. Advisors’s Portfolio MTEM Stock Details MTEM Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2018 Q2	–	Sell	-826	Closed	-$99K	–	1846
2018 Q1	$99K	Sell	826 -208	-20%	-$31.3K	﹤0.01%	1357
2017 Q4	$155K	Buy	+1,034	New	+$130K	0.01%	1206
2016 Q1	–	Sell	-211	Closed	-$16K	–	1724
2015 Q4	$16K	Buy	+211	New	+$104K	﹤0.01%	1418

Other funds holding MTEM

Caxton Corporation Princeton, New Jersey $4.02M AUM 256.08% 1-Year Est. Return

Perceptive Advisors New York $5.12B AUM 314.02% 1-Year Est. Return

BVF Inc San Francisco, California $3.14B AUM 249.53% 1-Year Est. Return

First Eagle Investment Management New York $59B AUM 32.99% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

LSC

Lyon Street Capital Sausalito, California $67M AUM

Deutsche Bank Frankfurt Am Main Ge, Germany $303B AUM 30.15% 1-Year Est. Return

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

Nexthera Capital New York $120M AUM 10.01% 1-Year Est. Return

A.R.T. Advisors's MTEM Position: Q2 2018 in Review

A.R.T. Advisors sold out of Molecular Templates, Inc. (MTEM) in Q2 2018, closing a stake of 826 shares — an estimated $99K sold.

A.R.T. Advisors first reported a position in MTEM in Q4 2015 and held it in 3 quarters. The position peaked at $155K in Q4 2017. 52 funds tracked by Wall St. Rank hold MTEM as of Q2 2018.

A.R.T. Advisors reported no remaining Molecular Templates, Inc. position as of Q2 2018 after selling out during the quarter.
A.R.T. Advisors sold 826 Molecular Templates, Inc. shares in Q2 2018, an estimated $99K.
A.R.T. Advisors first reported a position in Molecular Templates, Inc. in Q4 2015 and held it in 3 quarters.
A.R.T. Advisors's Molecular Templates, Inc. position peaked at $155K in Q4 2017.
52 funds tracked by Wall St. Rank held Molecular Templates, Inc. as of Q2 2018.

Based on A.R.T. Advisors's 13F filing for Q2 2018, filed 14 Aug 2018.